Walleye Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Walleye Capital's AMLX Position: Q3 2026 in Review
Walleye Capital reduced its Amylyx Pharmaceuticals (AMLX) stake by 100% in Q3 2026, selling an estimated $4.93M and leaving 767 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5632.
Walleye Capital first reported a position in AMLX in Q1 2022 and has held it in 15 quarters since. The position peaked at $8.58M in Q4 2023. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Walleye Capital held 767 shares of Amylyx Pharmaceuticals worth $22.3K as of Q3 2026.
- Walleye Capital sold 185,821 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $4.93M.
- Amylyx Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5632 holding.
- Walleye Capital first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
- Walleye Capital's Amylyx Pharmaceuticals position peaked at $8.58M in Q4 2023.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.